Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05384132 · ClinicalTrials.gov registry record · NA
Novel Dental Gel as an Adjunct to Scaling and Root Planing
A NA study of Periodontal Diseases and Gingival Diseases, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 76
- Enrollment target
- 1
- Study location
NCT05384132: Recruiting NA study of Periodontal Diseases and Gingival Diseases, sponsored by University of Alabama at Birmingham.
NCT05384132 is a NA study of Periodontal Diseases and Gingival Diseases that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 76 participants, below the 157-participant average among 15 other Periodontal Diseases trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05384132, a NA study of Periodontal Diseases and Gingival Diseases, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the use of Livionex Dental Gel (LDG) as a home care product in reducing probing pocket depth (PD) beyond the effect achieved by the current standard of care with SRP in periodontitis patients.
Primary Outcome
Incremental reduction in PD compared to the active control at Day 180 for those sites with PD \> 4 mm as compared to control.
Conditions Studied
Interventions
- OTHER SRP + Livfresh Dental Gel
- OTHER SRP + standard flouride dentifrice
Study Locations (1)
Alabama
- Unversity of Alabama at Birmingham, School of Dentistry - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2022-10-14 |
| Est. Completion | 2028-10-30 |
| Phase | NA |
What NCT05384132 shows while recruiting
NCT05384132 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 157-participant average among 15 other Periodontal Diseases trials with a reported enrollment target (52% lower).
The record links to 5 conditions, with Periodontal Diseases appearing as the primary indexed condition, and to 2 interventions - of which SRP + Livfresh Dental Gel is the first listed.
NCT05384132 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT05384132 about?
NCT05384132 is a clinical study titled "Novel Dental Gel as an Adjunct to Scaling and Root Planing". This study will evaluate the use of Livionex Dental Gel (LDG) as a home care product in reducing probing pocket depth (PD) beyond the effect achieved by the current standard of care with SRP in periodontitis patients.
What is the current status of trial NCT05384132?
This trial is currently recruiting. It is a NA study. The enrollment target is 76 participants. The study started on 2022-10-14. Estimated completion is 2028-10-30.
What conditions does trial NCT05384132 study?
This clinical trial studies the following conditions: Periodontal Diseases, Gingival Diseases, Plaque, Dental, Gingival Pocket, Gum Bleed.
What interventions are being tested in trial NCT05384132?
The interventions under investigation include: SRP + Livfresh Dental Gel (OTHER), SRP + standard flouride dentifrice (OTHER).
Who is sponsoring clinical trial NCT05384132?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05384132 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Periodontal Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05384132's enrollment target sits among peer trials
76 8th of 15 higher than 8 of 15 other Periodontal Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Periodontal Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Oral Health Intervention in Adult Primary Care
RECRUITING · NA
-
An Evaluation of the Effect of the Erchonia FX-405 Laser as an Adjunctive Treatment of Periodontitis
RECRUITING · NA
-
F.L.O.S.S. Project (Facilitated Lessons on Oral and Systemic Health in Survivors)
RECRUITING · NA
-
Microsurgery and Periodontal Healing
RECRUITING · NA
-
Addition of Dehydrated Human Amnion-Chorion Membrane During Scaling and Root Planing
ACTIVE NOT RECRUITING · NA
-
Application of L-PRF in Periodontal Surgery
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI